跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zerbaxa - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zerbaxa
Approved
STANDARD
Zerbaxa
Steri-Pharma, LLC
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
66e2cd30be6dcb35
Company
Steri-Pharma, LLC
Type
Standard
Approval Details
Approval Id
66e2cd30be6dcb35
Drug Approval Philippines Name
Zerbaxa
Product Name
Zerbaxa
Registration Number
DR-XY45714
Brand Name
Zerbaxa
Generic Name
Ceftolozane (as sulfate) + Tazobactam (as sodium)
Dosage Form
Powder for Injection (I.V. Infusion)
Dosage Strength
1 g/500 mg
Manufacturer
Steri-Pharma, LLC
Importer
Merck Sharp & Dohme (I.A.) LLC
Company Detail Path
/organization/steri-pharma-llc
Issuance Date
16 February 2023
Expiry Date
19 December 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
66e2cd30be6dcb35
Type
Standard
Back to Philippines FDA Approvals